NO20004880D0 - Anvendelse av inhibitorer av retinsyreaktivitet for Õ nedsette hÕrtap - Google Patents

Anvendelse av inhibitorer av retinsyreaktivitet for Õ nedsette hÕrtap

Info

Publication number
NO20004880D0
NO20004880D0 NO20004880A NO20004880A NO20004880D0 NO 20004880 D0 NO20004880 D0 NO 20004880D0 NO 20004880 A NO20004880 A NO 20004880A NO 20004880 A NO20004880 A NO 20004880A NO 20004880 D0 NO20004880 D0 NO 20004880D0
Authority
NO
Norway
Prior art keywords
inhibitors
retinoic acid
hair loss
acid activity
reduce hair
Prior art date
Application number
NO20004880A
Other languages
English (en)
Other versions
NO20004880L (no
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO20004880D0 publication Critical patent/NO20004880D0/no
Publication of NO20004880L publication Critical patent/NO20004880L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20004880A 1998-03-31 2000-09-28 Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap NO20004880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (fr) 1998-03-31 1998-03-31 Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique
PCT/FR1999/000687 WO1999049838A1 (fr) 1998-03-31 1999-03-24 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour retarder la chute des cheveux

Publications (2)

Publication Number Publication Date
NO20004880D0 true NO20004880D0 (no) 2000-09-28
NO20004880L NO20004880L (no) 2000-11-30

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004880A NO20004880L (no) 1998-03-31 2000-09-28 Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap

Country Status (16)

Country Link
EP (1) EP1066017A1 (no)
JP (1) JP2002509870A (no)
KR (1) KR20010042104A (no)
CN (1) CN1298290A (no)
AR (1) AR015551A1 (no)
AU (1) AU2938899A (no)
BR (1) BR9908411A (no)
CA (1) CA2324899A1 (no)
FR (1) FR2776511B1 (no)
HU (1) HUP0102411A3 (no)
IL (1) IL137859A0 (no)
NO (1) NO20004880L (no)
PL (1) PL343004A1 (no)
RU (1) RU2193877C2 (no)
WO (1) WO1999049838A1 (no)
ZA (1) ZA200004483B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2270667C2 (ru) * 2003-09-01 2006-02-27 Лариса Яковлевна Циукаева Лосьон против роста волос (варианты) и способ замедления роста волос

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
KR100485642B1 (ko) * 1996-03-18 2005-09-30 에자이 가부시키가이샤 축합고리함유카르복실산유도체

Also Published As

Publication number Publication date
CA2324899A1 (fr) 1999-10-07
CN1298290A (zh) 2001-06-06
PL343004A1 (en) 2001-07-30
JP2002509870A (ja) 2002-04-02
HUP0102411A2 (hu) 2001-11-28
BR9908411A (pt) 2000-12-05
IL137859A0 (en) 2001-10-31
HUP0102411A3 (en) 2002-12-28
EP1066017A1 (fr) 2001-01-10
KR20010042104A (ko) 2001-05-25
WO1999049838A1 (fr) 1999-10-07
ZA200004483B (en) 2002-02-27
AR015551A1 (es) 2001-05-02
NO20004880L (no) 2000-11-30
AU2938899A (en) 1999-10-18
FR2776511B1 (fr) 2001-05-11
FR2776511A1 (fr) 1999-10-01
RU2193877C2 (ru) 2002-12-10

Similar Documents

Publication Publication Date Title
PL328871A1 (en) Substituted derivatives of 4-hydroxyphenyloalcanic acid exhibiting antagonistic activity in respect to ppar-gamma
PT1037880E (pt) Anilidas mimeticas do acido retinoico
PT1070069E (pt) Derivados biciclicos do acido hidroxamico
BR0009158B1 (pt) composição tópica baseada em ácido ascórbico para o tratamento de danos na pele
ID26171A (id) Proses untuk oksidasi langsung olefin-olefin ke oksida-oksida olefin
FI970430L (fi) Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
ATE273008T1 (de) Verwendung von nikotinsäurederivate zur behandlung von dna-schäden bei hautzellen
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
PT1084102E (pt) Novos derivados do acido 3-aril-propionico e analogos
ID28111A (id) Metoda untuk meningkatkan kesehatan kulit
DE69813935D1 (de) Verwendung von Retinoiden zur Induzierung von Hautpigmentierung
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
NO20004188D0 (no) Vandige formuleringer av parasittfjerningsmidler for anvendelse pÕ huden
ATE232378T1 (de) Reinigungspflaster zur verbesserung des hautzustandes
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
PT1007512E (pt) 2-aminopiridinas alcoxi-substituidas ramificadas utilizadas como inibidores de nos
EE03745B1 (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ID29792A (id) Formulasi lepas terkendali untuk mengobati corp
DE69704197D1 (de) Verwendung von Citronensäureestern zur Verbesserung der Auswaschbarkeit ölhaltiger kosmetischer Zusammensetzungen
DE59712085D1 (de) Katalytisch aktive Wirkstoffkombination zur Verstärkung der Bleichwirkung
NO20004880D0 (no) Anvendelse av inhibitorer av retinsyreaktivitet for Õ nedsette hÕrtap